ES8401946A1 - Procedimiento para la preparacion de sulfonilureas. - Google Patents

Procedimiento para la preparacion de sulfonilureas.

Info

Publication number
ES8401946A1
ES8401946A1 ES520706A ES520706A ES8401946A1 ES 8401946 A1 ES8401946 A1 ES 8401946A1 ES 520706 A ES520706 A ES 520706A ES 520706 A ES520706 A ES 520706A ES 8401946 A1 ES8401946 A1 ES 8401946A1
Authority
ES
Spain
Prior art keywords
preparation
alcohyl
carbon atoms
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES520706A
Other languages
English (en)
Spanish (es)
Other versions
ES520706A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES520706A0 publication Critical patent/ES520706A0/es
Publication of ES8401946A1 publication Critical patent/ES8401946A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
ES520706A 1982-03-19 1983-03-17 Procedimiento para la preparacion de sulfonilureas. Expired ES8401946A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823210063 DE3210063A1 (de) 1982-03-19 1982-03-19 Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung

Publications (2)

Publication Number Publication Date
ES520706A0 ES520706A0 (es) 1984-01-01
ES8401946A1 true ES8401946A1 (es) 1984-01-01

Family

ID=6158708

Family Applications (1)

Application Number Title Priority Date Filing Date
ES520706A Expired ES8401946A1 (es) 1982-03-19 1983-03-17 Procedimiento para la preparacion de sulfonilureas.

Country Status (12)

Country Link
EP (1) EP0089597A3 (en, 2012)
JP (1) JPS58170760A (en, 2012)
KR (1) KR840004081A (en, 2012)
AU (1) AU1266383A (en, 2012)
DE (1) DE3210063A1 (en, 2012)
DK (1) DK125583A (en, 2012)
ES (1) ES8401946A1 (en, 2012)
FI (1) FI830898A7 (en, 2012)
GR (1) GR77163B (en, 2012)
NO (1) NO830966L (en, 2012)
PT (1) PT76411B (en, 2012)
ZA (1) ZA831910B (en, 2012)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002256085A1 (en) * 2001-04-06 2002-10-21 Smithkline Beecham Corporation Quinoline inhibitors of hyak1 and hyak3 kinases
AU2011295407B2 (en) 2010-08-27 2016-01-21 Grunenthal Gmbh Substituted quinoline-3-carboxamides as KCNQ2/3 modulators
RU2595894C2 (ru) * 2010-08-27 2016-08-27 Грюненталь Гмбх Замещенные 2-окси-хинолин-3-карбоксамиды в качестве модуляторов kcnq2/3
EP2609084A1 (en) 2010-08-27 2013-07-03 Grünenthal GmbH Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
CN103189357B (zh) 2010-08-27 2015-11-25 格吕伦塔尔有限公司 作为kcnq2/3调节剂的取代的2-氧代-和2-硫代-二氢喹啉-3-甲酰胺
EP2611780A1 (en) 2010-09-01 2013-07-10 Grünenthal GmbH Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
ES2620379T3 (es) * 2013-01-31 2017-06-28 Vertex Pharmaceuticals Inc. Quinolina y quinoxalina amidas como moduladores de canales de sodio

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819633A (en) * 1970-04-01 1974-06-25 Erba Carlo Spa (iso)quinolyl sulfonylureas having antidiabetic activity
DE2621958A1 (de) * 1976-05-18 1977-12-08 Hoechst Ag Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
DE3134780A1 (de) * 1981-09-02 1983-03-10 Hoechst Ag, 6000 Frankfurt "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung"

Also Published As

Publication number Publication date
DK125583A (da) 1983-09-20
NO830966L (no) 1983-09-20
GR77163B (en, 2012) 1984-09-10
KR840004081A (ko) 1984-10-06
DK125583D0 (da) 1983-03-18
FI830898L (fi) 1983-09-20
AU1266383A (en) 1983-09-22
FI830898A7 (fi) 1983-09-20
ES520706A0 (es) 1984-01-01
JPS58170760A (ja) 1983-10-07
PT76411B (de) 1985-12-16
EP0089597A3 (de) 1984-05-09
EP0089597A2 (de) 1983-09-28
DE3210063A1 (de) 1983-09-22
ZA831910B (en) 1983-11-30
FI830898A0 (fi) 1983-03-17
PT76411A (de) 1983-04-01

Similar Documents

Publication Publication Date Title
ES8504140A1 (es) Procedimiento para la preparacion de nuevos bencimidazoles substituidos
ES2090065T3 (es) Esteres de acido fosforico, procedimiento para su fabricacion y su utilizacion como agente dispersante.
ES2045038T5 (es) Soluciones y dispersiones acuosas de productos de poliadicion de poliisocianato, un procedimiento para la obtencion de las soluciones y dispersiones acuosas asi como su empleo como adhesivo.
ES8405766A1 (es) Procedimiento para preparar derivados de fenil-1-piperidino-2-propanol
ES8201948A1 (es) Un procedimiento para la preparacion de nuevos derivados transisomericos de 4-fenil-1,2,3,4- tetrahidro-1-naftalenamina.
GT197851174A (es) Compuestos organicos y el procedimiento para preparar dichoscompuestos
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES8306125A1 (es) Un procedimiento para la preparacion de derivados de fenil- piperacina.
MX7012A (es) Procedimiento para preparar derivados de acido-cis,endo-2-azabiciclo-(5.3.0.)-decan-3-carboxilico.
ES2152938T3 (es) 1(2h)-isoquinolinas sustituidas antiarritmicas y cardioprotectoras, procedimiento para su produccion, medicamento que las contiene y su uso para la produccion de un medicamento para combatir fallos cardiacos.
ES454964A1 (es) Un procedimiento para la preparacion de acido 7-d-(-)-alfa- amino-alfa-(p-hidroxifenilacetamido) desacetoxicefalospora- nico, hidrato o sales farmaceuticamente aceptables del mis- mo.
MX9204110A (es) Derivados del acido quinolonacarboxilico y procedimiento para su preparacion.
ES479423A1 (es) Procedimiento para la preparacion de 2-2-tenoiltio-propio- nil-glicina.
ES8401946A1 (es) Procedimiento para la preparacion de sulfonilureas.
ES8607248A1 (es) Procedimiento para preparar nuevos derivados de benzazepina
ES2052761T3 (es) Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene.
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
ES8301884A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8701738A1 (es) Procedimiento para preparar nuevos 1,2,4-triazolo-carbamatos
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
ES8307820A1 (es) Procedimiento para la obtencion de esteres del acido 7b-2-(2amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido-3-cefem-4-carboxilico.
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES2004036A6 (es) Procedimiento para la preparacion de derivados gonadoliberinos que contienen un acido aminocarboxilio aromatico en posicion 6
MX169465B (es) Procedimiento para la obtencion de derivados del acido pirimidilfosforico y productos intermedios
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos